Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhone® RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patients
BOSTON, October 27, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced a new feature for its ClinPhone® RTSM (randomization and trial supply management) Mobile App that addresses the workflow and safety issues commonly associated with the packaging, transport, and storage of temperature-sensitive medications. The industry-first capability will provide end-to-end temperature monitoring that records the complete temperature history of a product from the point of packaging through to patient dispensation via in-pack wireless sensors.
The new offering meets a growing need for the biopharmaceutical industry to manage the increasing number of critically temperature-sensitive medications being evaluated in clinical trials (“cold chain management”). By 2020, it is expected that eight out of the top 10 global biopharmaceutical products will require cold chain management. Research has shown that the majority of temperature excursions impacting medications occur during storage at the clinical site. Using wireless sensors combined with PAREXEL’s ClinPhone RTSM service, sites and logistics teams are able to track temperatures from the point of secondary packaging through dispensation to the patient.
“At PAREXEL, we continually innovate to better ensure patient safety and data accuracy while simplifying tasks for clinical trial sites. This important new functionality builds on the existing capabilities of PAREXEL’s Active Tracking Service and the ClinPhone® RTSM Mobile App to better manage the chain of custody record for clinical supplies,” said Ubavka DeNoble, Corporate Vice President of Patient Technology Services, PAREXEL. “For treatments that require cold chain handling, just a few degrees can make a huge difference, potentially impacting the safety of the medication, leading to the risk of the drug being unavailable for the next patient visit or affecting patient safety. With this new offering, clients will reduce safety risks and costs associated with temperature-compromised stock.”
The new feature will be demoed today and tomorrow during the CBI 7th Annual Interactive Response Technologies in Clinical Trials conference, taking place in Philadelphia, PA. It is the latest addition to PAREXEL’s Connected Journey™ of more than 40 data-driven services, and is currently available via the ClinPhone RTSM Mobile App.
PAREXEL’s ClinPhone RTSM service has been deployed on over 4,000 studies and more than 2.5 million patients, with the largest of those studies randomizing and supplying more than 60,000 patients. PAREXEL’s Active Tracking service controls and monitors the distribution of clinical trial supplies through its Clinical Trial Supplies and Logistics experts and global network of over 50 GMP compliant depots. The ClinPhone RTSM Mobile App is available worldwide for use on Android and iOS platforms.
“Global Trends in Clinical Trial Logistics: 2020 Perspective.” 2015. Corex.